drugset / Trial / NCT00750139

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis

NCT00750139

Phase 3 Completed 707 enrolled Merz North America, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo, when used in subjects with tinea pedis (athlete's foot).

Timeline

Start
2008-08
Primary completion
2009-08
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified 1 % Topical
Subject Naftifine Other / unclassified 2 % Topical

Indications